Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer Legislation to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results